Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia

Objective: The study sought to assess the impact of treatment with beta-blocker (BB) or ACE inhibitor/angiotensin receptor blocker (ACEi/ARB) on secondary survival in patients presenting with ventricular tachyarrhythmia. Background: Data regarding outcome of patients presenting with ventricular tach...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schupp, Tobias (VerfasserIn) , Behnes, Michael (VerfasserIn) , Weiß, Christel (VerfasserIn) , Lang, Siegfried (VerfasserIn) , Reiser, Linda (VerfasserIn) , Kern-Bollow, Armin (VerfasserIn) , Taton, Gabriel (VerfasserIn) , Reichelt, Thomas (VerfasserIn) , Ellguth, Dominik (VerfasserIn) , Engelke, Niko (VerfasserIn) , Ansari, Uzair (VerfasserIn) , El-Battrawy, Ibrahim (VerfasserIn) , Borggrefe, Martin (VerfasserIn) , Akın, Ibrahim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 3 August 2018
In: Cardiovascular drugs and therapy
Year: 2018, Jahrgang: 32, Heft: 4, Pages: 353-363
ISSN:1573-7241
DOI:10.1007/s10557-018-6812-z
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s10557-018-6812-z
Volltext
Verfasserangaben:Tobias Schupp, Michael Behnes, Christel Weiß, Christoph Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Uzair Ansari, Ibrahim El-Battrawy, Thomas Bertsch, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin

MARC

LEADER 00000caa a2200000 c 4500
001 167236146X
003 DE-627
005 20230426122736.0
007 cr uuu---uuuuu
008 190828s2018 xx |||||o 00| ||eng c
024 7 |a 10.1007/s10557-018-6812-z  |2 doi 
035 |a (DE-627)167236146X 
035 |a (DE-599)KXP167236146X 
035 |a (OCoLC)1341238628 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schupp, Tobias  |d 1995-  |e VerfasserIn  |0 (DE-588)1168611091  |0 (DE-627)103237862X  |0 (DE-576)51163840X  |4 aut 
245 1 0 |a Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia  |c Tobias Schupp, Michael Behnes, Christel Weiß, Christoph Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Uzair Ansari, Ibrahim El-Battrawy, Thomas Bertsch, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin 
264 1 |c 3 August 2018 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.08.2019 
520 |a Objective: The study sought to assess the impact of treatment with beta-blocker (BB) or ACE inhibitor/angiotensin receptor blocker (ACEi/ARB) on secondary survival in patients presenting with ventricular tachyarrhythmia. Background: Data regarding outcome of patients presenting with ventricular tachyarrhythmia treated with BB and ACEi/ARB is limited. Methods: A large retrospective registry was used including consecutive patients presenting with ventricular tachycardia and fibrillation from 2002 to 2016 on admission. Applying propensity-score matching for harmonization, the impact of “BB” and “ACEi/ARB” was comparatively evaluated. The primary prognostic outcome was long-term all-cause death at 3 years. Results: A total of 972 matched patients were included. Both patients with BB (long-term mortality rate 18 versus 27%; log rank p = 0.041; HR = 0.661; 95% CI = 0.443-0.986; p = 0.043) and with ACEi/ARB (long-term mortality rate 13 versus 23%; log rank p = 0.004; HR = 0.544; 95% CI = 0.359-0.824; p = 0.004) revealed better secondary survival compared to patients without after presenting with ventricular tachyarrhythmia on admission. The prognostic benefit of BB was comparable to ACEi/ARB (long-term mortality rate 21 versus 26%; log rank p = 0.539). Conclusion: BB and ACEi/ARB were associated with improved secondary survival in patients surviving ventricular tachyarrhythmia on admission. 
650 4 |a ACE inhibitor 
650 4 |a Angiotensin receptor blocker 
650 4 |a Beta-blocker 
650 4 |a Medical treatment 
650 4 |a Mortality 
650 4 |a Pharmacological drugs 
650 4 |a Sudden cardiac death 
650 4 |a Ventricular fibrillation 
650 4 |a Ventricular tachycardia 
700 1 |a Behnes, Michael  |d 1982-  |e VerfasserIn  |0 (DE-588)138373361  |0 (DE-627)696560518  |0 (DE-576)307333949  |4 aut 
700 1 |a Weiß, Christel  |d 1958-  |e VerfasserIn  |0 (DE-588)123287707  |0 (DE-627)082463417  |0 (DE-576)168356104  |4 aut 
700 1 |a Lang, Siegfried  |d 1955-  |e VerfasserIn  |0 (DE-588)1026112613  |0 (DE-627)726109290  |0 (DE-576)371365473  |4 aut 
700 1 |a Reiser, Linda  |d 1994-  |e VerfasserIn  |0 (DE-588)1168611156  |0 (DE-627)1032378743  |0 (DE-576)511638981  |4 aut 
700 1 |a Kern-Bollow, Armin  |d 1985-  |e VerfasserIn  |0 (DE-588)1168611180  |0 (DE-627)103237876X  |0 (DE-576)511638965  |4 aut 
700 1 |a Taton, Gabriel  |d 1985-  |e VerfasserIn  |0 (DE-588)1168611199  |0 (DE-627)1032378794  |0 (DE-576)511638957  |4 aut 
700 1 |a Reichelt, Thomas  |d 1987-  |e VerfasserIn  |0 (DE-588)1168611245  |0 (DE-627)1032378875  |0 (DE-576)511638922  |4 aut 
700 1 |a Ellguth, Dominik  |d 1991-  |e VerfasserIn  |0 (DE-588)1168611288  |0 (DE-627)103237893X  |0 (DE-576)511638892  |4 aut 
700 1 |a Engelke, Niko  |d 1992-  |e VerfasserIn  |0 (DE-588)1168611318  |0 (DE-627)1032378964  |0 (DE-576)511638884  |4 aut 
700 1 |a Ansari, Uzair  |d 1982-  |e VerfasserIn  |0 (DE-588)1150892633  |0 (DE-627)1011156733  |0 (DE-576)49732878X  |4 aut 
700 1 |a El-Battrawy, Ibrahim  |d 1987-  |e VerfasserIn  |0 (DE-588)1033436917  |0 (DE-627)741219549  |0 (DE-576)38084673X  |4 aut 
700 1 |a Borggrefe, Martin  |e VerfasserIn  |0 (DE-588)1025920546  |0 (DE-627)725574232  |0 (DE-576)370913426  |4 aut 
700 1 |a Akın, Ibrahim  |d 1978-  |e VerfasserIn  |0 (DE-588)132322293  |0 (DE-627)521039010  |0 (DE-576)299074366  |4 aut 
773 0 8 |i Enthalten in  |t Cardiovascular drugs and therapy  |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1987  |g 32(2018), 4, Seite 353-363  |h Online-Ressource  |w (DE-627)320429237  |w (DE-600)2003553-6  |w (DE-576)106890727  |x 1573-7241  |7 nnas  |a Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia 
773 1 8 |g volume:32  |g year:2018  |g number:4  |g pages:353-363  |g extent:11  |a Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia 
856 4 0 |u https://doi.org/10.1007/s10557-018-6812-z  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190828 
993 |a Article 
994 |a 2018 
998 |g 132322293  |a Akın, Ibrahim  |m 132322293:Akın, Ibrahim  |d 60000  |d 61000  |e 60000PA132322293  |e 61000PA132322293  |k 0/60000/  |k 1/60000/61000/  |p 18  |y j 
998 |g 1025920546  |a Borggrefe, Martin  |m 1025920546:Borggrefe, Martin  |d 60000  |d 61000  |e 60000PB1025920546  |e 61000PB1025920546  |k 0/60000/  |k 1/60000/61000/  |p 17 
998 |g 1033436917  |a El-Battrawy, Ibrahim  |m 1033436917:El-Battrawy, Ibrahim  |d 60000  |d 61000  |e 60000PE1033436917  |e 61000PE1033436917  |k 0/60000/  |k 1/60000/61000/  |p 13 
998 |g 1150892633  |a Ansari, Uzair  |m 1150892633:Ansari, Uzair  |d 60000  |d 61000  |e 60000PA1150892633  |e 61000PA1150892633  |k 0/60000/  |k 1/60000/61000/  |p 12 
998 |g 1168611318  |a Engelke, Niko  |m 1168611318:Engelke, Niko  |d 60000  |e 60000PE1168611318  |k 0/60000/  |p 11 
998 |g 1168611288  |a Ellguth, Dominik  |m 1168611288:Ellguth, Dominik  |d 60000  |d 61000  |e 60000PE1168611288  |e 61000PE1168611288  |k 0/60000/  |k 1/60000/61000/  |p 10 
998 |g 1168611245  |a Reichelt, Thomas  |m 1168611245:Reichelt, Thomas  |d 60000  |e 60000PR1168611245  |k 0/60000/  |p 9 
998 |g 1168611199  |a Taton, Gabriel  |m 1168611199:Taton, Gabriel  |d 60000  |e 60000PT1168611199  |k 0/60000/  |p 8 
998 |g 1168611180  |a Kern-Bollow, Armin  |m 1168611180:Kern-Bollow, Armin  |d 60000  |e 60000PK1168611180  |k 0/60000/  |p 7 
998 |g 1168611156  |a Reiser, Linda  |m 1168611156:Reiser, Linda  |d 60000  |e 60000PR1168611156  |k 0/60000/  |p 6 
998 |g 1026112613  |a Lang, Siegfried  |m 1026112613:Lang, Siegfried  |d 60000  |d 61000  |e 60000PL1026112613  |e 61000PL1026112613  |k 0/60000/  |k 1/60000/61000/  |p 5 
998 |g 123287707  |a Weiß, Christel  |m 123287707:Weiß, Christel  |d 60000  |d 60200  |d 60250  |e 60000PW123287707  |e 60200PW123287707  |e 60250PW123287707  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60250/  |p 3 
998 |g 138373361  |a Behnes, Michael  |m 138373361:Behnes, Michael  |d 60000  |d 61000  |e 60000PB138373361  |e 61000PB138373361  |k 0/60000/  |k 1/60000/61000/  |p 2 
998 |g 1168611091  |a Schupp, Tobias  |m 1168611091:Schupp, Tobias  |d 60000  |d 61000  |e 60000PS1168611091  |e 61000PS1168611091  |k 0/60000/  |k 1/60000/61000/  |p 1  |x j 
999 |a KXP-PPN167236146X  |e 3509435540 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"id":{"eki":["320429237"],"zdb":["2003553-6"],"issn":["1573-7241"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"320429237","type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmiaCardiovascular drugs and therapy","pubHistory":["1.1987/88 -"],"note":["Gesehen am 05.12.05","Ungezählte Beil.: Suppl"],"origin":[{"publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedKey":"1987","dateIssuedDisp":"1987-"}],"title":[{"title_sort":"Cardiovascular drugs and therapy","subtitle":"CDT","title":"Cardiovascular drugs and therapy"}],"titleAlt":[{"title":"CDT"}],"part":{"volume":"32","extent":"11","text":"32(2018), 4, Seite 353-363","issue":"4","pages":"353-363","year":"2018"},"language":["eng"]}],"recId":"167236146X","name":{"displayForm":["Tobias Schupp, Michael Behnes, Christel Weiß, Christoph Nienaber, Siegfried Lang, Linda Reiser, Armin Bollow, Gabriel Taton, Thomas Reichelt, Dominik Ellguth, Niko Engelke, Uzair Ansari, Ibrahim El-Battrawy, Thomas Bertsch, Muharrem Akin, Kambis Mashayekhi, Martin Borggrefe, Ibrahim Akin"]},"physDesc":[{"extent":"11 S."}],"id":{"eki":["167236146X"],"doi":["10.1007/s10557-018-6812-z"]},"note":["Gesehen am 28.08.2019"],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"3 August 2018"}],"title":[{"title":"Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia","title_sort":"Beta-blockers and ACE inhibitors are associated with improved survival secondary to ventricular tachyarrhythmia"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Tobias","role":"aut","family":"Schupp","display":"Schupp, Tobias"},{"display":"Behnes, Michael","family":"Behnes","given":"Michael","role":"aut"},{"family":"Weiß","display":"Weiß, Christel","given":"Christel","role":"aut"},{"display":"Lang, Siegfried","family":"Lang","role":"aut","given":"Siegfried"},{"display":"Reiser, Linda","family":"Reiser","given":"Linda","role":"aut"},{"family":"Kern-Bollow","display":"Kern-Bollow, Armin","role":"aut","given":"Armin"},{"role":"aut","given":"Gabriel","display":"Taton, Gabriel","family":"Taton"},{"display":"Reichelt, Thomas","family":"Reichelt","role":"aut","given":"Thomas"},{"given":"Dominik","role":"aut","family":"Ellguth","display":"Ellguth, Dominik"},{"family":"Engelke","display":"Engelke, Niko","given":"Niko","role":"aut"},{"given":"Uzair","role":"aut","family":"Ansari","display":"Ansari, Uzair"},{"role":"aut","given":"Ibrahim","family":"El-Battrawy","display":"El-Battrawy, Ibrahim"},{"role":"aut","given":"Martin","display":"Borggrefe, Martin","family":"Borggrefe"},{"display":"Akın, Ibrahim","family":"Akın","given":"Ibrahim","role":"aut"}]} 
SRT |a SCHUPPTOBIBETABLOCKE3201